នៅក្នុងវិស័យឱសថដ៏ធំ ការទិញដ៏ល្អបំផុតគឺ AstraZeneca ក្នុងតម្លៃក្រោម 56 ដុល្លារ

GlaxoSmithKline PLC (LON:GSK), ចនសុន & ចនសុន (FRA:JNJ), and AstraZeneca PLC (LON:AZN) are certainly the best in the big pharma industry. As the companies compete in the drug wars, investors only want to know which stock provides the best investment opportunity.

AstraZeneca wins investors in the big pharma wars

While GSK returned only 6.84% in capital gains since September 2019, JNJ rose by 31.28%. AstraZeneca reported 69.80% in stock market returns. These results indicate AstraZeneca as the ultimate winner. However, investors need to know whether buying the stocks at prevailing market prices would attract similar returns.

តើអ្នកកំពុងស្វែងរកព័ត៌មានរហ័សព័ត៌មានជំនួយក្តៅនិងការវិភាគទីផ្សារមែនទេ?

ចុះឈ្មោះសម្រាប់ព្រឹត្តិប័ត្រ Invezz ថ្ងៃនេះ។

GSK at $43 is only $3 above the support of $40 and only $2 below the resistance of $45. The highly constricted range demonstrates why GSK would face significant challenges providing more than 10% in returns.

JNJ has a support level of $150. At the time of presenting this analysis, the stock was trading at the resistance level of $176. The highest level that the company hit is $179. The RSI at 61 is bullish, and the stock is likely to hit the overbought region.

Consequently, the stock will most likely shed value to levels between the support and midline of $165. The analysis marks JNJ as a sell at the prevailing price.

Lastly, AstraZeneca at $65 is moving to find a new high. The price has a support level of $52. The bullish momentum could be hitting a peak, and the stock will most certainly correct to a price of approximately $56 before gaining again.

សេចក្តីសង្ខេប

Since AstraZeneca has the highest rate of return among the three companies, it is considered a better investment. However, investors should wait for the price to pull back to levels between $52 and $56 before investing. All three companies are bullish but AstraZeneca has a higher price range and better potential for high returns.

កន្លែងដែលត្រូវទិញឥឡូវនេះ

ដើម្បីវិនិយោគសាមញ្ញនិងងាយស្រួលអ្នកប្រើប្រាស់ត្រូវការឈ្មួញកណ្តាលដែលមានកម្រៃទាបជាមួយនឹងកំណត់ត្រាដែលអាចទុកចិត្តបាន។ ឈ្មួញកណ្តាលខាងក្រោមត្រូវបានវាយតម្លៃខ្ពស់ទទួលស្គាល់ទូទាំងពិភពលោកនិងមានសុវត្ថិភាពក្នុងការប្រើប្រាស់:

1. Etoroជឿទុកចិត្តដោយអ្នកប្រើប្រាស់ជាង 13 លាននាក់នៅទូទាំងពិភពលោក។ ចុះឈ្មោះនៅទីនេះ>
2. ប៊ីតហ្វ្លីយើរសាមញ្ញ ងាយស្រួលប្រើ និងគ្រប់គ្រង។ ចុះឈ្មោះនៅទីនេះ>

* ការវិនិយោគ Cryptoasset មិនត្រូវបានគ្រប់គ្រងនៅក្នុងបណ្តាប្រទេស EU និងចក្រភពអង់គ្លេសមួយចំនួន។ គ្មានការការពារអ្នកប្រើប្រាស់។ ដើមទុនរបស់អ្នកស្ថិតក្នុងហានិភ័យ។